Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 12 836 / https://doi.org/10.3332/ecancer.2018.836

Case Report

Cryptococcal meningoencephalitis in patients with mantle cell lymphoma on ibrutinib

Ibrutinib, a Bruton’s tyrosine kinase inhibitor, has been increasingly widely used in relapsed and refractory mantle cell lymphoma (MCL) and chronic lymphocytic leukaemia [1, 2]. With its use becoming more common, there have been emerging case reports of opportunistic infections like cryptococcal infections [3–8]. These infections in patients receiving ibrutinib were mostly reported in patients with chronic lymphocytic leukaemia, who have poor immune reconstitution. Here, we report two cases of cryptococcal meningoencephalitis in patients with MCL on ibrutinib.

Keywords: Cryptococcal Meningoencephalitis, Mental cell lymphoma, ibrutinib

Categories:

Haematology oncology

Loading Article Metrics ... Please wait

Related articles

Review: Lung cancer patients have the highest malignancy-associated suicide rate in USA: a population-based analysis

Abstract | Full Article | PDF Published: 16 Aug 2018 / https://doi.org/10.3332/ecancer.2018.859

Case Report: Recurrent dermatofibrosarcoma protuberans: challenging a surgeon’s dexterity for the ‘tricky’ margins

Abstract | Full Article | PDF Published: 13 Aug 2018 / https://doi.org/10.3332/ecancer.2018.858

Policy: The understanding of healthcare workers on the content of palliative care policy in Shesilweni Swaziland: a qualitative study

Abstract | Full Article | PDF Published: 10 Aug 2018 / https://doi.org/10.3332/ecancer.2018.857

Case Report: Two cases of white globe appearance in non-cancerous stomach

Abstract | Full Article | PDF Published: 07 Aug 2018 / https://doi.org/10.3332/ecancer.2018.856

Research: Survival probabilities and trends for lip, oral cavity and oropharynx cancers in the Northern Region of Portugal in the period 2000–2009

Abstract | Full Article | PDF Published: 31 Jul 2018 / https://doi.org/10.3332/ecancer.2018.855



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation